72 research outputs found

    SOME THOUGHTS ON THE MECHANICAL ANATOMY OF THE FEMALE PELVIS1 1Received January, 1969.

    Get PDF
    The obstetric significance of the female bony pelvis lies firstly, in its role during pregnancy wherein it protects the pelvic viscera and provides the point of attachment for the muscles of the abdominal walls, and secondly, during labour when the bony pelvis is the “immovable object” through which must pass the more pliable and compressible foetus

    Solid immersion lens applications for nanophotonic devices

    Get PDF
    Solid immersion lens (SIL) microscopy combines the advantages of conventional microscopy with those of near-field techniques, and is being increasingly adopted across a diverse range of technologies and applications. A comprehensive overview of the state-of-the-art in this rapidly expanding subject is therefore increasingly relevant. Important benefits are enabled by SIL-focusing, including an improved lateral and axial spatial profiling resolution when a SIL is used in laser-scanning microscopy or excitation, and an improved collection efficiency when a SIL is used in a light-collection mode, for example in fluorescence micro-spectroscopy. These advantages arise from the increase in numerical aperture (NA) that is provided by a SIL. Other SIL-enhanced improvements, for example spherical-aberration-free sub-surface imaging, are a fundamental consequence of the aplanatic imaging condition that results from the spherical geometry of the SIL. Beginning with an introduction to the theory of SIL imaging, the unique properties of SILs are exposed to provide advantages in applications involving the interrogation of photonic and electronic nanostructures. Such applications range from the sub-surface examination of the complex three-dimensional microstructures fabricated in silicon integrated circuits, to quantum photoluminescence and transmission measurements in semiconductor quantum dot nanostructures

    Invited review: Cattle lameness detection with accelerometers

    Get PDF
    peer-reviewedLocomotion scoring is time consuming and is not commonly completed on farms. Farmers also underestimate their herds' lameness prevalence, a knowledge gap that impedes lameness management. Automation of lameness detection could address this knowledge gap and facilitate improved lameness management. The literature pertinent to adding lameness detection to accelerometers is reviewed in this paper. Options for lameness detection systems are examined including the choice of sensor, raw data collected, variables extracted, and statistical classification methods used. Two categories of variables derived from accelerometer-based systems are examined. These categories are behavior measures such as lying and measures of gait. For example, one measure of gait is the time a leg is swinging during a gait cycle. Some behavior-focused studies have reported accuracy levels of greater than 80%. Cow gait measures have been investigated to a lesser extent than behavior. However, classification accuracies as high as 91% using gait measures have been reported with hardware likely to be practical for commercial farms. The need for even higher accuracy and potential barriers to adoption are discussed. Significant progress is still required to realize a system with sufficient specificity and sensitivity. Lameness detection systems using 1 accelerometer per cow and a resolution lower than 100 Hz with gait measurement functions are suggested to balance cost and data requirements. However, gait measurement using accelerometers is rather underdeveloped. Therefore, a high priority should be given to the development of novel gait measures and testing their ability to differentiate lame from nonlame cows

    Plasma gut hormone levels in 37 patients with pheochromocytomas

    Full text link
    Pheochromocytomas are usually recognized by the effects of overproduction of catecholamines, but there are clinical features that cannot be ascribed to catecholamine excess that may be due to vasoactive peptides. We, therefore, measured blood levels of vasoactive intestinal peptides (VIP), substance P, somatostatin (SS), and motilin in 50 instances in 37 patients with pheochromocytomas-21 malignant, 10 benign intra-adrenal, and 6 ectopic (5 paracardial and 1 perirenal). Hormone levels were considered raised if the level was more than 3 S.D. above the mean value found in 52 healthy subjects. Of the 37 patients, 20 (54%) had an abnormality in 1 or more gut hormone levels. The most common abnormality was a raised SS in 9/37 (24%). In addition to these, however, 3 (8%) others had raised VIP, 5 (13.5%) raised motilin, and 3 (8%) raised substance P. Patients with benign adrenal adenomas had raised levels of SS and substance P. Ectopic pheochromocytomas produced only SS in addition to catecholamines, but malignant pheochromocytomas could secrete all 4 peptides, and more than 1 in the same patient. We conclude that pheochromocytomas may secrete multiple vasoactive peptides, and they are more likely to do so if malignant. Somatostatin is the most commonly secreted peptide and is found with benign adrenal and ectopic (paracardiac) tumors. If the level of more than 1 peptide is elevated, the likelihood of malignancy is significantly increased . Les phĂ©ochromocytomes sont gĂ©nĂ©ralement dĂ©celĂ©spar les effets dĂ»s Ă  la surproduction de catĂ©cholamines, mais certains troubles ne peuvent ĂȘtre attribuĂ©s Ă  ce phĂ©nomĂšne et relĂšvent peut ĂȘtre de l'action de peptides vasoactifs. Les auteurs se sont donc attachĂ©s Ă  doser dans le sang le VIP, la substance P, la somatostatine (SS), et la motiline. Ces dosages furent pratiquĂ©s 50 fois chez 37 malades porteurs de phĂ©ochromocytomes: 21 malins, 10 bĂ©nins et 6 ectopiques (5 paracardiaque et 1 pĂ©ri-rĂ©nal). Les taux des hormones furent considĂ©rĂ©s comme Ă©levĂ©s lorsque leur niveau fut supĂ©rieur Ă  plus de 3 fois le taux de 52 sujets sains. Sur les 37 malades 20 (54%) prĂ©sentaient un excĂšs d'une ou de plusieurs hormones digestives. L'anomalie constatĂ©e la plus frĂ©quente fut l'Ă©lĂ©vation de la SS (9 fois sur 37 soit 24%). AjoutĂ©e Ă  ce fait fut l'Ă©lĂ©vation de la VIP chez 3 sujets (8%), de la motiline chez 5 (13.5%) et de la substance P chez 3 (8%). Les phĂ©ochromocytomes bĂ©nins surrĂ©naliens prĂ©sentaient Ă  la fois une Ă©lĂ©vation du taux de la SS et de la substance P. Les phĂ©ochromocytomes ectopiques en revanche prĂ©sentaient seulement une Ă©lĂ©vation de la SS. Les phĂ©ochromocytomes malins pouvaient sĂ©crĂ©ter les 4 peptides ou plus d'un chez le mĂȘme malade. En conclusion les phĂ©ochromocytomes peuvent secrĂ©ter de multiples peptides vasoactifs et plus particuliĂšrement lorsqu'ils sont malins. La SS est la substance qui est la plus souvent secrĂ©tĂ©e et elle est trouvĂ©e dans les tumeurs bĂ©nignes surrĂ©naliennes ou ectopiques. Si plus d'une de ces substances est produite en excĂšs les risques de malignitĂ© de la tumeur sont significativement plus importants. Los feocromocitomas generalmente son diagnosticados por los efectos del exceso de producciĂłn de catecolaminas pero hay caracterĂ­sticas clĂ­nicas que no pueden ser atribuidas al exceso de catecolaminas y que pueden ser mĂĄs bien manifestaciĂłn de pĂ©ptidos vasoactivos. Hemos establecido los niveles sanguĂ­neos del pĂ©ptido intestinal vasoactivo (VIP), de la sustancia P, de la somatostatina (SS), y de la motilina en 50 determinaciones en 37 pacientes con feocromocitomas; 21 malignos, 10 benignos intra-adrenales, y 6 ectĂłpicos (5 paracardiales y 1 perirrenal). Se considerĂł que los niveles hormonales estaban elevados cuando el nivel era de mĂĄs de 3 de desviaciĂłn estandar sobre el valor promedio en 52 individuos normales. De 37 pacientes, 20 (54%) presentaron un valor anormal en 1 o mĂĄs determinaciones del nivel de hormonas intestinales. La anormalidad mĂĄs comĂșn fue la elevaciĂłn de la SS en 9/37 (24%). AdemĂĄs de esto, sinembargo, otros 3 (8%) presentaban elevaciĂłn de VIP, 5 (13.5%) elevaciĂłn de sustancia P. Los adenomas suprarrenales benignos exhibieron niveles elevados de SS y de sustancia P. Los feocromocitomas ectĂłpicos demostraron producciĂłn sĂłlo de SS ademĂĄs de catecolaminas, pero los feocromocitomas malignos demostraron ser capaces de secretar todos los 4 pĂ©ptidos, y mĂĄs de 1 en el mismo paciente. Hemos llegado a la conclusiĂłn de que los feocromocitomas pueden secretar mĂșltiples peptidos vasoactivos y que Ă©sto tiende a ocurrir cuando son malignos. La SS es el pĂ©ptido mĂĄs frecuentemente secretado y se lo encuentra en los tumores suprarrenales benigno y ectĂłpico (paracardiacos). Si se encuentran niveles elevados de mĂĄs de 1 pĂ©ptido, la posibilidad de malignidad aparece significativamente aumentada.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/41274/1/268_2005_Article_BF01655534.pd

    Search for resonances decaying into photon pairs in 139 fb−1 of pp collisions at √s = 13 TeV with the ATLAS detector

    Get PDF
    Searches for new resonances in the diphoton final state, with spin 0 as predicted by theories with an extended Higgs sector and with spin 2 using a warped extra-dimension benchmark model, are presented using 139 fb−1 of √s = 13 TeV pp collision data collected by the ATLAS experiment at the LHC. No significant deviation from the Standard Model is observed and upper limits are placed on the production cross-section times branching ratio to two photons as a function of the resonance mass

    DUX hunting-clinical features and diagnostic challenges associated with DUX4-rearranged leukaemia

    No full text
    DUX4-rearrangement (DUX4r) is a recently discovered recurrent genomic lesion reported in 4-7% of childhood B cell acute lymphoblastic leukaemia (B-ALL) cases. This subtype has favourable outcomes, especially in children and adolescents treated with intensive chemotherapy. The fusion most commonly links the hypervariable IGH gene to DUX4 a gene located within the D4Z4 macrosatellite repeat on chromosome 4, with a homologous polymorphic repeat on chromosome 10. DUX4r is cryptic to most standard diagnostic techniques, and difficult to identify even with next generation sequencing assays. This review summarises the clinical features and molecular genetics of DUX4r B-ALL and proposes prospective new diagnostic methods.Jacqueline A. Rehn, Matthew J. O’Connor, Deborah L. White and David T. Yeun
    • 

    corecore